References
- Austrian R. Pneumococcus: the first one hundred years. Rev Infect Dis. 1981; 3: 183–9.
- MacFarlane JT, Finch RG, Ward, MJ, Macrae AD. Hospital study of adult community acquired pneumonia. Lancet. 1982; ii: 255–8.
- Williams WW, Hickson MA, Kane MA, Kindal AP, Spika JG, Hinman AR. Immunization policies and vaccine coverage among adults. The risk for missed opportunities. Ann Intern Med. 1988; 108: 616–25.
- Steven N, Wright P. Pneumococcal immunisation and the healthy elderly. Lancet. 1992; 340: 103637.
- Chattopadhyay B, Al-Zahawi. Septicaemia and its unacceptable high mortality in the elderly J Infect. 1983;7:134–8.
- Austrian R, Gold J. Pneumococcal bacteremia with special reference to bacteremic pneumococcal pneumonia. Ann Intern Med. 1 1964; 60 759–76.
- Appelbaum PC. Antimicrobial resistance in Streptococcus pneumoniae: an overview. Clin Infect Dis. 1992; 15: 77–83.
- Centers for Disease Control. Update on adult immunizations: Recommendations of the ACIP’ MMWR. 1991; 40 (No RR-12): 42–4.
- Musher DM. Infections caused by Streptococcus pneumoniae. Clinical spectrum, pathogenesis, immunity, and treatment. Clin Infect Dis. 1992; 14: 801–9.
- Schwartz JS. Pneumococcal vaccine: clinical efficacy and effectiveness. Ann Intern Med. 1982; 148: 1136–59.
- Sniadack DH, Breiman RF, Williams WW Pneumococcal vaccine in the 1990s. Infect Dis Clin Pract. 1992; 1: 58–61.
- Gaillat J, Zmirae D, Mallaret NR et al. Essai clinique du vaccin antipneumococcique chez des personnes agfies vivant en institution. Rev Epidemiol Sante Publ. 1985; 33: 437–44.
- Shapiro ED, Berg AT, Austrian R et al. The protective efficacy of polyvalent pneumococcal polysaccharide vaccine. N Engl J Med. 1991; 325: 1453–460.
- Robbins JB, Austrian R, Lee C-J et al. Considerations for formulating the second generation pneumococcal capsular polysaccharide vaccine with emphasis on the cross-reactive types within groups. J Infect Dis. 1983; 148: 1136–59.
- Verhaegen J, Glupczynski Y, Verbist L et al. Capsular types and antibiotic sensitivity of pneumococci isolated from serious infections in Belgium (1980-I988).£«ri Clin Microbiol Infect Dis. 1990; 9: 390–5.
- ACIP. Pneumococcal polysaccharide vaccine. MMWR. 1989; 38: 64–76.
- Schwarz B, Breiman RF. Pneumococcal immunization: from policy to practice. JAMA. 1990; 264:1154–55.
- Bruyn GAW. Pneumococcal immunisation and the healthy elderly. Lancet. 1992; 340: 1418–19.
- Fedson D, Henrichsen J, Makela PH, Austrian R. WHO recommendations on pneumococcal vaccination. Immunization of elderly people with polyvalent pneumococcal vaccine. Infection. 1989; 17: 437–41.
- LaForce FM, EickhoffTC. Pneumococcal vaccine: an emerging consensus. Ann Intern Med. 1988; 108: 757–9.
- Gable CB, Holzer SS, Engelhart L et al. Pneumococcal vaccine efficacy and associated cost savings. JAMA. 1990; 264: 2910–15.